Acinetobacter baumannii Resistance to Sulbactam/Durlobactam: A Systematic Review

Infections caused by carbapenem-resistant Acinetobacter baumannii (CRAB) have limited therapeutic options. Sulbactam-durlobactam is a combination of two βlactamase inhibitors with activity against CRAB under phase 3 clinical investigation. We performed a systematic review on in vitro studies reporti...

Descripción completa

Detalles Bibliográficos
Autores principales: Principe, Luigi, Di Bella, Stefano, Conti, Jacopo, Perilli, Mariagrazia, Piccirilli, Alessandra, Mussini, Cristina, Decorti, Giuliana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774100/
https://www.ncbi.nlm.nih.gov/pubmed/36551450
http://dx.doi.org/10.3390/antibiotics11121793

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9774100/
https://www.ncbi.nlm.nih.gov/pubmed/36551450
http://dx.doi.org/10.3390/antibiotics11121793

Ejemplares similares